Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Interventions

TIC10 compound 3 vorasidenib 1 tovorafenib 1 pembrolizumab 1 efineptakin alfa 1 avapritinib 1 Vaccination 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Glioma × Vaccination × Clear all

NCT05356312 2024-03-01

Glioblastoma and Individualized Therapies

Zentrum fur Humangenetik Tuebingen

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡